Anthem Biosciences IPO Allotment: Dates, Details, and Status Update

Overview

Anthem Bio­sciences, a Ben­galu­ru-based leader in the Con­tract Research, Devel­op­ment, and Man­u­fac­tur­ing Orga­ni­za­tion (CRDMO) seg­ment, launched its much-antic­i­pat­ed Ini­tial Pub­lic Offer­ing (IPO) in July 2025. The offer­ing attract­ed sig­nif­i­cant atten­tion due to the company’s rep­u­ta­tion for inno­v­a­tive bio­phar­ma ser­vices and robust growth.

Timeline of Events

Event	Date	Sta­tus
IPO Opened	July 14, 2025	Com­plet­ed
IPO Closed	July 16, 2025	Com­plet­ed
Allot­ment Final­iza­tion	July 17, 2025	Com­plet­ed (basis of allot­ment pub­lished)
Ini­ti­a­tion of Refunds	July 18, 2025	Expect­ed to com­mence
Shares Cred­it­ed to Demat Accounts	July 18, 2025	Expect­ed by end of day
List­ing on BSE & NSE	July 21, 2025	Upcom­ing (Mon­day)

IPO Details

• Total Issue Size: ₹3,395 crore (100% Offer for Sale, 5.96 crore shares)
• Price Band: ₹540–₹570 per share
• Min­i­mum Lot Size: 26 shares (min­i­mum invest­ment: ₹14,040)
• Lead Man­agers: JM Finan­cial, Cit­i­group, JP Mor­gan India, Nomu­ra
• Reg­is­trar: Kfin Tech­nolo­gies Lim­it­ed

Subscription Data

Cat­e­go­ry	Sub­scrip­tion Times
Qual­i­fied Insti­tu­tion­al Buy­ers (QIB)	182.65x
Non-Insti­tu­tion­al Investors (NII)	42.36x
Retail Indi­vid­ual Investors (RII)	5.64x
Over­all	63.86x

• The extreme­ly high QIB and NII par­tic­i­pa­tion under­scores insti­tu­tion­al con­fi­dence in Anthem Bio­sciences’ busi­ness mod­el and out­look.

Allotment Status: Step-By-Step Guide

1. Allot­ment Basis Final­ized:
   On July 17, 2025, the reg­is­trar, Kfin Tech­nolo­gies, pub­lished the basis of allotment—a doc­u­ment out­lin­ing the cat­e­go­ry-wise allot­ment ratio. This doc­u­ment details how the avail­able shares were dis­trib­uted among appli­cants in each cat­e­go­ry.
2. How to Check Your Allot­ment:
   Investors can check their IPO allot­ment sta­tus via three main chan­nels:
   • The offi­cial web­site of Kfin Tech­nolo­gies (IPO allot­ment sec­tion), by enter­ing their appli­ca­tion num­ber, PAN, or DP/Client ID.
   • The BSE/NSE web­sites’ IPO sta­tus pages, which require sim­i­lar infor­ma­tion.
   • Email/SMS noti­fi­ca­tions may also be sent direct­ly to investors, depend­ing on reg­is­trar and bank poli­cies.
3. Share Cred­it and Refunds:
   • Suc­cess­ful appli­cants are sched­uled to have their allot­ted shares cred­it­ed to their demat accounts on July 18, 2025.
   • Refunds for non-allot­tees also begin pro­cess­ing on July 18, 2025, with com­ple­tion expect­ed by the fol­low­ing bank­ing day.

Grey Market Activity & Listing Expectations

• Grey Mar­ket Pre­mi­um (GMP): As of July 17, 2025, the grey mar­ket tracked a pre­mi­um of approx­i­mate­ly ₹150–₹160 per share. This sug­gests an implied list­ing price near ₹720 (above the upper price band), indi­cat­ing strong demand and an antic­i­pat­ed 26–28% gain for investors at list­ing.
• Expect­ed Debut: Anthem Bio­sciences shares are sched­uled to list on both NSE and BSE on Mon­day, July 21, 2025. Spec­u­la­tion around the list­ing is intense, giv­en the robust sub­scrip­tion fig­ures and pos­i­tive mar­ket sen­ti­ment.

Key Points for Investors

• High Over­sub­scrip­tion: The over­whelm­ing sub­scrip­tion rates, espe­cial­ly from QIBs, high­light Anthem’s high mar­ket con­fi­dence and like­ly strong list­ing per­for­mance.
• Offi­cial Chan­nels: Only check the allot­ment sta­tus via Kfin Tech­nolo­gies, BSE, or NSE plat­forms to avoid mis­in­for­ma­tion.
• Next Steps: Mon­i­tor your demat account for share cred­it and check your bank account for any applic­a­ble refund by July 18–19, 2025.

Anthem Bio­sciences’ IPO jour­ney stands out for its over­sub­scrip­tion rates, mar­ket opti­mism, and antic­i­pa­tion for its mar­ket debut. Investors remain keen­ly watch­ful of the list­ing day on July 21, expect­ing notable activ­i­ty in the stock­’s ear­ly trad­ing.